These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22280094)

  • 1. Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation.
    Gatto F; Redaelli D; Salvadè A; Marzorati S; Sacchetti B; Ferina C; Roobrouck VD; Bertola F; Romano M; Villani G; Antolini L; Rovelli A; Verfaillie CM; Biondi A; Riminucci M; Bianco P; Serafini M
    Stem Cells Dev; 2012 Jun; 21(9):1466-77. PubMed ID: 22280094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome).
    Tolar J; Park IH; Xia L; Lees CJ; Peacock B; Webber B; McElmurry RT; Eide CR; Orchard PJ; Kyba M; Osborn MJ; Lund TC; Wagner JE; Daley GQ; Blazar BR
    Blood; 2011 Jan; 117(3):839-47. PubMed ID: 21037085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type I.
    Baxter MA; Wynn RF; Deakin JA; Bellantuono I; Edington KG; Cooper A; Besley GT; Church HJ; Wraith JE; Carr TF; Fairbairn LJ
    Blood; 2002 Mar; 99(5):1857-9. PubMed ID: 11861306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.
    Wang D; Shukla C; Liu X; Schoeb TR; Clarke LA; Bedwell DM; Keeling KM
    Mol Genet Metab; 2010 Jan; 99(1):62-71. PubMed ID: 19751987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
    Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
    Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden.
    de Castro LF; Burke AB; Wang HD; Tsai J; Florenzano P; Pan KS; Bhattacharyya N; Boyce AM; Gafni RI; Molinolo AA; Robey PG; Collins MT
    J Bone Miner Res; 2019 Feb; 34(2):290-294. PubMed ID: 30496606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome.
    Wang D; Zhang W; Kalfa TA; Grabowski G; Davies S; Malik P; Pan D
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19958-63. PubMed ID: 19903883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development.
    Baxter MA; Wynn RF; Schyma L; Holmes DK; Wraith JE; Fairbairn LJ; Bellantuono I
    J Inherit Metab Dis; 2005; 28(6):1045-53. PubMed ID: 16435198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of mucopolysaccharidosis I.
    Swaroop M; Brooks MJ; Gieser L; Swaroop A; Zheng W
    Hum Mol Genet; 2018 Oct; 27(20):3612-3626. PubMed ID: 30052969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation.
    Keeling KM; Brooks DA; Hopwood JJ; Li P; Thompson JN; Bedwell DM
    Hum Mol Genet; 2001 Feb; 10(3):291-9. PubMed ID: 11159948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel splice site IDUA gene mutation in Tunisian pedigrees with hurler syndrome.
    Chkioua L; Boudabous H; Jaballi I; Grissa O; Turkia HB; Tebib N; Laradi S
    Diagn Pathol; 2018 May; 13(1):35. PubMed ID: 29843745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells.
    Donsante S; Pievani A; Palmisano B; Finamore M; Fazio G; Corsi A; Biondi A; Tomatsu S; Piazza R; Serafini M; Riminucci M
    JCI Insight; 2024 Mar; 9(5):. PubMed ID: 38456506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
    Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I.
    Kuehn SC; Koehne T; Cornils K; Markmann S; Riedel C; Pestka JM; Schweizer M; Baldauf C; Yorgan TA; Krause M; Keller J; Neven M; Breyer S; Stuecker R; Muschol N; Busse B; Braulke T; Fehse B; Amling M; Schinke T
    Hum Mol Genet; 2015 Dec; 24(24):7075-86. PubMed ID: 26427607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel p.E276K IDUA mutation decreasing α-L-iduronidase activity causes mucopolysaccharidosis type I.
    Prommajan K; Ausavarat S; Srichomthong C; Puangsricharern V; Suphapeetiporn K; Shotelersuk V
    Mol Vis; 2011 Feb; 17():456-60. PubMed ID: 21364962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term nonsense suppression therapy moderates MPS I-H disease progression.
    Gunn G; Dai Y; Du M; Belakhov V; Kandasamy J; Schoeb TR; Baasov T; Bedwell DM; Keeling KM
    Mol Genet Metab; 2014 Mar; 111(3):374-381. PubMed ID: 24411223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation.
    Xu G; Liu K; Anderson J; Patrene K; Lentzsch S; Roodman GD; Ouyang H
    Blood; 2012 May; 119(18):4205-14. PubMed ID: 22427205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of age on regulation of human osteoclast differentiation.
    Chung PL; Zhou S; Eslami B; Shen L; LeBoff MS; Glowacki J
    J Cell Biochem; 2014 Aug; 115(8):1412-9. PubMed ID: 24700654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.